Small peptides under 20 kDa bind little stain and slip through standard blotting membranes, so conventional SDS-PAGE and Western protocols fail. This guide covers Tricine gel systems, changes to crosslinker, pH and urea, transfer conditions that retain small species, and control peptides for…
Detecting a peptide under 20 kDa by SDS-PAGE or Western blotting fails for mechanical reasons, not for lack of material. The peptide binds far less stain than a larger protein of equal molar amount, so the band never develops. During transfer, the peptide is small enough to travel through the membrane rather than bind it. Neither failure is solved by loading more sample or exposing the blot longer. Both are solved by changing the gel chemistry, the membrane, and the transfer timing. Quantification is a separate trap: the mass printed on the tube label is mostly not peptide, because the lyophilized powder contains water and salts. This article gives the electrophoretic, blotting, and concentration-measurement choices that work for peptides under 20 to 30 kDa, and it says plainly which recommendations rest on protocol experience rather than controlled comparisons.
Coomassie brilliant blue binds chiefly to arginine, lysine, and histidine residues and to aromatic side chains, through a combination of electrostatic and hydrophobic contacts. The amount of dye held in a band therefore scales with the number of basic and aromatic residues in the protein. A 60 kDa protein presents dozens of such residues; a 5 kDa peptide may present one or two. Per mole, and even per microgram, a small peptide captures a fraction of the dye that a large protein captures. That asymmetry is why a gel loaded with a microgram of a 5 kDa peptide can show nothing while a microgram of a 50 kDa protein stains intensely. The protocol literature on small peptide detection states the limitation directly: smaller peptides bind less Coomassie than larger proteins, which is why Coomassie and silver staining both struggle at this size.
Silver staining has a second problem. The method develops signal from the protein mass and includes fixation and washing steps, and small peptides diffuse in and out of polyacrylamide faster than large proteins. They can be lost from the gel during those steps even when they entered it cleanly. The practical consequence: on a stained gel, the absence of a band at the expected molecular weight is not evidence that the peptide is absent.
Two adjustments help within the limits of staining. Load more sample; for a purified peptide the cost is trivial, and the extra mass partially compensates for low dye binding. Do not change the total acrylamide percentage unless the peptide has migrated off the gel, because total acrylamide is not the limiting variable at this size. The pore structure, set mostly by the choice of gel system and the crosslinker, is what needs to change.
Tricine-SDS-PAGE is the workhorse for small proteins. The system replaces glycine with tricine as the trailing ion in the stacking gel. In a standard Laemmli gel, the glycine front creates a discontinuity that compresses proteins into a sharp zone only above roughly 15-20 kDa; below that, bands broaden and resolution collapses. Tricine has a higher mobility at the operative pH, so the stacking front stays sharp deep into the low kilodalton range, and the system tolerates the high acrylamide concentrations that would make a Laemmli gel impractically slow. The protocol literature places the useful range of Tricine-SDS-PAGE at 1-100 kDa and recommends it whenever the target is below 30 kDa.
The worked example in that literature uses myoglobin fragments generated by cyanogen bromide cleavage, separated on a 10% T, 3% C gel. Because the fragment set includes pieces below 10 kDa, the same gel composition exposes the difference between the Tricine and Laemmli systems directly. A composition of 10% T, 3% C is not extreme; it shows that the trailing ion, not the total acrylamide, is what drives the improvement for small species.
If the peptide enters the gel but the band is diffuse or missing, three adjustments are reported. Increase the crosslinker percentage in a regular 17% gel. Raise the resolving gel pH from 8.8 to 9.5. Add 4-8 M urea to the resolving gel. The crosslinker change is mechanistically straightforward: more bis-acrylamide gives a tighter mesh and more sieving of small peptides, at the cost of brittle gels and slower migration. Urea keeps hydrophobic and aggregation-prone peptides denatured so they migrate as monomers rather than smears. Old urea solutions contain ammonium cyanate, which carbamylates free amino groups and changes the mass and charge of the peptide, so the urea must be fresh.
The pH 9.5 adjustment is reported to sharpen bands, but its mechanism is less clearly documented than the crosslinker or urea effects. A higher resolving pH changes the effective mobility of SDS-peptide complexes and the polymerization environment, and it may improve local stacking for very small species. Related guidance: if standard Tricine-SDS-PAGE gives poor results, a Tris-tricine gel system may resolve better. The two names are used loosely, and the operative difference is the buffer formulation, so switching systems means switching buffers and re-checking against size markers.
These gel modifications are mainstream protocol guidance and each has a plausible mechanism, but the originating protocol does not supply controlled comparisons. Plan to test the settings against your own peptide rather than assuming that pH 9.5 with 6 M urea will work on the first attempt.
Western blotting beats staining for small peptides because antibody binding is specific to an epitope and does not depend on dye-binding residues. The sensitivity advantage is real, but it is wasted if the peptide leaves the membrane. Two forces work against retention. The electric field continues to drive the peptide after it reaches the membrane, and a peptide under roughly 20 kDa can pass through the pores of a conventional 0.45 µm membrane. And small, hydrophilic peptides bind membrane material weakly, because retention on nitrocellulose and PVDF is largely hydrophobic.
The standard fixes follow from those mechanisms. Use a 0.2 µm pore size membrane. Stack two membranes so the second catches what passes through the first. Transfer for less than 1 hour at 200 mA. The current setting matters because it limits the total charge delivered in the window; at 200 mA, the peptide spends less time being driven through the membrane. After transfer, probe both membranes with the antibody. A signal on the second membrane means the first is saturated, and the transfer should be shortened further.
Semi-dry transfer is a workable alternative. Transfer for 15-20 minutes at the current density recommended for the apparatus; most small peptides move onto the membrane within that window. The optimal conditions for very small peptides, below roughly 3 kDa, have not been defined by published comparisons, so the apparatus recommendation is a starting point, not a settled value.
Vacuum-assisted immunodetection shortens the antibody steps by a different route. Instead of relying on diffusion to carry reagents to the membrane, a vacuum draws the antibody and wash solutions through the membrane perpendicularly. The target peptide stays bound while the reagents transit the membrane, which reduces incubation and washing times. Whether the method requires a dedicated commercial apparatus is not specified in the protocol literature.
A biotin-labeled control peptide is the most direct way to know whether transfer worked. Synthesize the peptide of interest with a biotin group on the N- or C-terminus, run it in a separate lane, and detect it with streptavidin-conjugated HRP. If the control produces a signal, transfer and membrane binding succeeded, and a missing target band is an antibody problem. If the control is absent, the transfer conditions are the problem. Loaded at a known amount, the control also provides a semi-quantitative reference for comparing blots.
Two numbers on a peptide certificate describe different things. HPLC purity is the fraction of the peptide-related material that is the desired sequence; it reports whether the synthesis produced deletion or truncation contaminants. Peptide content is the fraction of the powder's mass that is peptide of any sequence. A product can be 98% pure by HPLC and have a net peptide content below half, because the rest of the powder mass is water and salts. Purity cannot be converted into concentration, and content cannot be inferred from purity.
This is why weighing lyophilized powder fails as a concentration method. The powder contains 10-70% water and salts by weight. Residual TFA counterions from HPLC purification, buffer salts, and bound water all count toward the weighed mass. Hydrophilic peptides are worse than hydrophobic ones, because they bind more water and retain more salt. At the high end of that range, dissolving 5 mg of powder can deliver less than half the expected amount of peptide. Amino acid analysis is the reference method for content: hydrolyze the powder, quantify the released residues, and compare them with the sequence's expected composition. It requires no chromophore and reports an absolute value.
UV spectrophotometry is the faster alternative when the sequence contains tryptophan or tyrosine. Measure the absorbance at 280 nm in a 1-cm cell at neutral pH. The molar extinction coefficient of the peptide is the sum of the contributions of its chromophoric residues:
| Residue | Wavelength | Molar extinction coefficient in a 1-cm cell |
| --- | --- | --- |
| Tryptophan | 280 nm | 5560 AU/mmole/ml |
| Tyrosine | 280 nm | 1200 AU/mmole/ml |
The coefficient for the peptide is therefore ε280 = nW × 5560 + nY × 1200 , where nW and nY are the numbers of tryptophan and tyrosine residues in the sequence. Concentration in mol/L equals A280 divided by ε280. A peptide with one tryptophan and one tyrosine has ε280 = 6760, so an A280 of 0.676 in a 1-cm cell corresponds to 0.1 mM. Multiply by molecular weight to express the result in mg/mL.
The UV method has limits. The coefficients hold at neutral pH, so measure in a buffered solution near pH 7. Absorbing species other than tryptophan and tyrosine, such as disulfide bonds and some buffer components, add error, so treat the value as an estimate when cystines are present. If the peptide contains neither tryptophan nor tyrosine, the 280 nm method does not work at all; amino acid analysis is then the only accurate route among the options described here.
The settings below condense the guidance into a single comparison. None of them is a guarantee; each is the first thing to try when a peptide under 20 kDa fails to appear.
| Parameter | Conventional setting | Small-peptide setting |
| --- | --- | --- |
| Gel system | Laemmli, glycine trailing ion | Tricine-SDS-PAGE |
| Total acrylamide | 10-15% T | 17% T unless the peptide runs off the gel |
| Crosslinker | Standard percentage | Increase it in the 17% gel |
| Resolving gel pH | 8.8 | 9.5 |
| Urea | None | 4-8 M |
| Membrane pore size | 0.45 µm | 0.2 µm |
| Membrane stack | Single membrane | Two membranes, both probed |
| Tank transfer | 1 hour or longer | Less than 1 hour at 200 mA |
| Semi-dry transfer | Apparatus default | 15-20 minutes at recommended current density |
Read the table as a set of independent dials. If the peptide runs off the gel, raise the total acrylamide. If it enters but smears, adjust crosslinker, pH, and urea. If it transfers but does not stay on the membrane, change pore size, stack count, and transfer time. Changing all of them at once makes it impossible to tell which adjustment mattered.
A workable sequence for a new peptide: separate on Tricine-SDS-PAGE with the biotin-labeled control in a spare lane; keep staining and destaining short because small peptides diffuse out of the gel during long incubations; transfer to two stacked 0.2 µm membranes for less than 1 hour at 200 mA, or semi-dry for 15-20 minutes; detect the target by antibody and the control by streptavidin-HRP; probe the second membrane if the target signal is weak. Once a signal appears, confirm identity by mass spectrometry. Staining and antibodies show only that something of the right size and epitope is present; mass spectrometry establishes the sequence.
The evidence base is uneven. Dye binding scaling with residue number is well established, which is why small peptides stain weakly. The advantage of Tricine-SDS-PAGE in the 1-100 kDa range is well established, and 30 kDa is the sensible threshold for choosing it. The retention effects of 0.2 µm membranes and short transfers follow directly from the physics of electrophoresis and are widely applied. That purity and content are different measurements, that lyophilized powder is 10-70% non-peptide mass, and that A280 with residue-based coefficients gives a defensible concentration for tryptophan- or tyrosine-containing peptides are all settled.
What is not settled: the optimal pore size, current density, and buffer for semi-dry transfer of very small peptides, defined by controlled data, do not exist. Whether vacuum-assisted detection requires dedicated equipment is unspecified. There is no standard design or purification scheme for the biotin-labeled control peptide. And the gel modifications, higher crosslinker, pH 9.5, and 4-8 M urea, rest on protocol experience with plausible mechanisms but without head-to-head published validation against conventional formulations.
For a researcher, the practical consequence is that small peptide detection is a tuning problem, not a single recipe. Keep the biotin control in every transfer until conditions are locked, change one gel variable at a time, and measure concentration by a method that counts peptide rather than powder. A band on a gel and a number on a tube label are only as trustworthy as the assumptions behind them.
Related reading: Best Canadian Peptide Vendors 2026: Ranked by Published Evidence, Peptide Pull-Down Assays for Mapping Protein Interactions, Tag-Assisted Peptide Synthesis: How TAPS Works and Its Benefits, Epimerization Risk in Peptide Synthesis: Pathways and Control.